• Mandeville’s amended deal with Quantropi allows Quantropi to pursue a SPAC-led US listing as an alternative path.
• If a US listing definitive agreement is signed by Nov. 30, 2026, Quantropi owes a non-refundable break fee of 500,000 Quantropi common shares.
• Quantropi can still complete the Mandeville transaction through May 31, 2027 if the US listing is terminated or fails to close.
• If the agreement later ends for reasons other than Mandeville breach, Quantropi must also reimburse costs tied to maintaining the TSXV listing, capped at C$ 100,000.
• Outside date for completing the Mandeville-Quantropi transaction moved to Jan. 31, 2027, with potential extension to May 31, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mandeville Ventures Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608071700NEWSFILECNPR____20260807_308750_1) on August 07, 2026, and is solely responsible for the information contained therein.